Skip to content

Advertisement

  • Correction
  • Open Access

Correction to: HIF prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction induced injury

  • 1,
  • 1,
  • 1,
  • 1,
  • 1,
  • 3,
  • 3,
  • 1,
  • 1,
  • 3,
  • 4,
  • 2,
  • 1,
  • 2,
  • 2,
  • 1,
  • 5,
  • 1 and
  • 1Email author
Contributed equally
Skeletal Muscle20188:38

https://doi.org/10.1186/s13395-018-0185-7

  • Published:

The original article was published in Skeletal Muscle 2018 8:35

Correction to: Skeletal Muscle (2018) 8:35

https://doi.org/10.1186/s13395-018-0179-5

Following publication of the original article [1], the authors flagged that there is a discrepancy with the Availability of data and materials statement on page 12 of the article.

This statement says that “Raw preclinical and clinical data for this manuscript will not be shared for logistical reasons.”

However, the authors state on page 10 of the article that “Anonymized individual participant data and study documents can be requested for further research from www.clinicalstudydatarequest.com.”

The policy at GlaxoSmithKline, Inc., the sponsor of this paper (see the Funding section on page 12), is consistent with the latter statement, of page 10.

As such, in the interest of full transparency, please be advised that the Availability of data and materials statement on page 12 of the article is void.

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Muscle Metabolism Discovery Performance Unit, GlaxoSmithKline, King of Prussia, PA, USA
(2)
Metabolic Pathways and Cardiovascular Therapy Area, GlaxoSmithKline, King of Prussia, PA, USA
(3)
Target Sciences, GlaxoSmithKline, King of Prussia, PA, USA
(4)
Clinical Statistics, GlaxoSmithKline, King of Prussia, PA, USA
(5)
School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia

Reference

  1. Billin AN, et al. HIF prolyl hydroxylase inhibition protects skeletal muscle from eccentric contraction induced injury. Skelet Muscle. 2018;8:35. https://doi.org/10.1186/s13395-018-0179-5.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2018

Advertisement